Nuwellis, Inc. (NUWE)
USD 0.84
(-12.5%)
USD 0.84
(-12.5%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -20.2 Million USD | -39.13% |
| 2022 | -14.52 Million USD | 25.81% |
| 2021 | -19.57 Million USD | -23.63% |
| 2020 | -15.83 Million USD | 12.58% |
| 2019 | -18.11 Million USD | -6.35% |
| 2018 | -17.03 Million USD | -27.28% |
| 2017 | -13.38 Million USD | 15.26% |
| 2016 | -15.79 Million USD | 40.59% |
| 2015 | -26.58 Million USD | -3.89% |
| 2014 | -25.58 Million USD | -17.6% |
| 2013 | -21.75 Million USD | -54.7% |
| 2012 | -14.06 Million USD | 13.16% |
| 2011 | -16.19 Million USD | -191.72% |
| 2010 | -5.55 Million USD | 14.85% |
| 2009 | -6.52 Million USD | 30.02% |
| 2008 | -9.31 Million USD | 4.81% |
| 2007 | -9.78 Million USD | -87.48% |
| 2006 | -5.22 Million USD | -36.78% |
| 2005 | -3.81 Million USD | -276.64% |
| 2004 | -1.01 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -7.72 Million USD | -103.88% |
| 2024 Q1 | -3.78 Million USD | 31.22% |
| 2023 Q4 | -5.5 Million USD | -63.47% |
| 2023 Q3 | -3.37 Million USD | 30.44% |
| 2023 FY | -20.2 Million USD | -39.13% |
| 2023 Q1 | -6.48 Million USD | -242.04% |
| 2023 Q2 | -4.84 Million USD | 25.29% |
| 2022 Q1 | -4.47 Million USD | -2.73% |
| 2022 Q2 | -4.28 Million USD | 4.18% |
| 2022 FY | -14.52 Million USD | 25.81% |
| 2022 Q4 | -1.89 Million USD | 51.01% |
| 2022 Q3 | -3.87 Million USD | 9.71% |
| 2021 Q3 | -5.27 Million USD | -11.44% |
| 2021 FY | -19.57 Million USD | -23.63% |
| 2021 Q2 | -4.73 Million USD | 9.39% |
| 2021 Q1 | -5.22 Million USD | -69.18% |
| 2021 Q4 | -4.35 Million USD | 17.41% |
| 2020 FY | -15.83 Million USD | 12.58% |
| 2020 Q1 | -4.56 Million USD | -2.7% |
| 2020 Q2 | -3.92 Million USD | 14.14% |
| 2020 Q3 | -4.26 Million USD | -8.62% |
| 2020 Q4 | -3.08 Million USD | 27.56% |
| 2019 Q2 | -4.43 Million USD | 6.28% |
| 2019 Q1 | -4.72 Million USD | -11.07% |
| 2019 FY | -18.11 Million USD | -6.35% |
| 2019 Q4 | -4.44 Million USD | 1.35% |
| 2019 Q3 | -4.5 Million USD | -1.78% |
| 2018 Q4 | -4.25 Million USD | -0.35% |
| 2018 Q3 | -4.24 Million USD | -1.44% |
| 2018 Q2 | -4.18 Million USD | 3.97% |
| 2018 Q1 | -4.35 Million USD | 38.99% |
| 2018 FY | -17.03 Million USD | -27.28% |
| 2017 FY | -13.38 Million USD | 15.26% |
| 2017 Q4 | -7.13 Million USD | -150.68% |
| 2017 Q3 | -2.84 Million USD | -15.83% |
| 2017 Q2 | -2.45 Million USD | -161.49% |
| 2017 Q1 | -940 Thousand USD | 67.6% |
| 2016 FY | -15.79 Million USD | 40.59% |
| 2016 Q4 | -2.9 Million USD | 25.94% |
| 2016 Q1 | -4.78 Million USD | 27.53% |
| 2016 Q3 | -3.91 Million USD | 6.47% |
| 2016 Q2 | -4.18 Million USD | 12.49% |
| 2015 FY | -26.58 Million USD | -3.89% |
| 2015 Q2 | -6.35 Million USD | 9.98% |
| 2015 Q3 | -6.55 Million USD | -3.15% |
| 2015 Q4 | -6.6 Million USD | -0.7% |
| 2015 Q1 | -7.06 Million USD | -4.75% |
| 2014 Q3 | -6.13 Million USD | 3.89% |
| 2014 Q2 | -6.38 Million USD | -0.76% |
| 2014 FY | -25.58 Million USD | -17.6% |
| 2014 Q4 | -6.74 Million USD | -9.96% |
| 2014 Q1 | -6.33 Million USD | 10.87% |
| 2013 Q3 | -6.03 Million USD | -43.01% |
| 2013 Q4 | -7.1 Million USD | -17.71% |
| 2013 FY | -21.75 Million USD | -54.7% |
| 2013 Q2 | -4.22 Million USD | 4.07% |
| 2013 Q1 | -4.39 Million USD | -8.19% |
| 2012 Q3 | -3.29 Million USD | -25.71% |
| 2012 Q2 | -2.62 Million USD | 35.75% |
| 2012 Q4 | -4.06 Million USD | -23.36% |
| 2012 FY | -14.06 Million USD | 13.16% |
| 2012 Q1 | -4.08 Million USD | 21.97% |
| 2011 Q4 | -5.23 Million USD | -21.35% |
| 2011 FY | -16.19 Million USD | -191.72% |
| 2011 Q3 | -4.31 Million USD | 0.0% |
| 2010 FY | -5.55 Million USD | 14.85% |
| 2009 FY | -6.52 Million USD | 30.02% |
| 2008 FY | -9.31 Million USD | 4.81% |
| 2007 FY | -9.78 Million USD | -87.48% |
| 2006 FY | -5.22 Million USD | -36.78% |
| 2005 FY | -3.81 Million USD | -276.64% |
| 2004 FY | -1.01 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 67.203% |
| BrainsWay Ltd. | -4.19 Million USD | -381.511% |
| Cerus Corporation | -37.48 Million USD | 46.094% |
| Envoy Medical, Inc. | -29.9 Million USD | 32.429% |
| electroCore, Inc. | -18.83 Million USD | -7.301% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -128.35% |
| IceCure Medical Ltd | -14.65 Million USD | -37.927% |
| Inogen, Inc. | -102.44 Million USD | 80.274% |
| OrthoPediatrics Corp. | -20.97 Million USD | 3.647% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 61.628% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | -47.026% |
| MaxCyte, Inc. | -37.92 Million USD | 46.71% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | -70.404% |
| Nexalin Technology, Inc. | -4.64 Million USD | -334.723% |
| Orthofix Medical Inc. | -151.39 Million USD | 86.651% |
| PAVmed Inc | -64.17 Million USD | 68.51% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 61.482% |
| RxSight, Inc. | -48.6 Million USD | 58.425% |
| Sight Sciences, Inc. | -55.54 Million USD | 63.618% |
| SI-BONE, Inc. | -43.33 Million USD | 53.367% |
| TELA Bio, Inc. | -46.66 Million USD | 56.693% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 59.196% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | -48.782% |
| Acutus Medical, Inc. | -81.66 Million USD | 75.253% |
| Talis Biomedical Corporation | -62 Million USD | 67.409% |
| Spectral AI, Inc. | -20.85 Million USD | 3.093% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 66.748% |
| CVRx, Inc. | -41.19 Million USD | 50.948% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 3256.69% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -84.468% |
| Bioventus Inc. | -156.23 Million USD | 87.065% |
| Venus Concept Inc. | -37.25 Million USD | 45.748% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 65.77% |
| LivaNova PLC | 17.54 Million USD | 215.177% |
| 908 Devices Inc. | -36.39 Million USD | 44.479% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 89.172% |
| Nemaura Medical Inc. | -14.14 Million USD | -42.883% |
| NeuroPace, Inc. | -32.95 Million USD | 38.679% |
| LENSAR, Inc. | -14.38 Million USD | -40.506% |
| Apyx Medical Corporation | -18.71 Million USD | -7.994% |
| Cutera, Inc. | -162.83 Million USD | 87.589% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | -86.602% |
| BioSig Technologies, Inc. | -29.04 Million USD | 30.412% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 75.554% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 8.511% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 129.833% |
| Axonics, Inc. | -6.08 Million USD | -231.948% |
| Outset Medical, Inc. | -172.79 Million USD | 88.305% |
| IRIDEX Corporation | -9.57 Million USD | -111.17% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 80.916% |
| IRadimed Corporation | 17.19 Million USD | 217.544% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -145.136% |
| INVO Bioscience, Inc. | -8.03 Million USD | -151.524% |
| Telesis Bio, Inc. | -47.72 Million USD | 57.654% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 297.296% |
| Varex Imaging Corporation | -47.7 Million USD | 57.633% |
| Quipt Home Medical Corp. | -2.78 Million USD | -625.898% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -79.063% |
| Pulmonx Corporation | -60.84 Million USD | 66.785% |
| Dynatronics Corporation | -2.69 Million USD | -649.114% |
| Modular Medical, Inc. | -17.47 Million USD | -15.678% |
| ReShape Lifesciences Inc. | -11.38 Million USD | -77.474% |
| Semler Scientific, Inc. | 20.58 Million USD | 198.183% |
| InMode Ltd. | 197.91 Million USD | 110.211% |
| Bruker Corporation | 427.2 Million USD | 104.731% |
| Cytosorbents Corporation | -28.5 Million USD | 29.11% |
| DexCom, Inc. | 541.5 Million USD | 103.732% |
| Align Technology, Inc. | 445.05 Million USD | 104.541% |
| Viveve Medical, Inc. | -22.02 Million USD | 8.254% |
| ZimVie Inc. | -393.28 Million USD | 94.861% |
| Movano Inc. | -29.28 Million USD | 30.987% |
| Cytek Biosciences, Inc. | -12.14 Million USD | -66.357% |
| Nexalin Technology, Inc. | -4.64 Million USD | -334.723% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 3256.69% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 90.922% |
| Profound Medical Corp. | -28.56 Million USD | 29.262% |
| Insulet Corporation | 206.3 Million USD | 109.796% |
| enVVeno Medical Corporation | -23.51 Million USD | 14.063% |
| Surmodics, Inc. | -11.54 Million USD | -75.091% |
| iCAD, Inc. | -4.84 Million USD | -316.938% |
| Biotricity, Inc. | -14.09 Million USD | -43.384% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 83.624% |
| Aethlon Medical, Inc. | -12.2 Million USD | -65.537% |
| InspireMD, Inc. | -19.91 Million USD | -1.471% |
| PAVmed Inc. | -64.17 Million USD | 68.51% |
| BIOLASE, Inc. | -20.63 Million USD | 2.05% |
| Beyond Air, Inc. | -60.24 Million USD | 66.454% |
| FONAR Corporation | 10.56 Million USD | 291.239% |
| AxoGen, Inc. | -21.71 Million USD | 6.94% |
| Vivani Medical, Inc. | -25.65 Million USD | 21.219% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 170.871% |
| Inari Medical, Inc. | -1.63 Million USD | -1135.269% |
| UFP Technologies, Inc. | 44.92 Million USD | 144.985% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -293.759% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -205.956% |
| Tenon Medical, Inc. | -15.58 Million USD | -29.703% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | -31.006% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 42.804% |
| AdaptHealth Corp. | -678.89 Million USD | 97.023% |
| Sintx Technologies, Inc. | -8.25 Million USD | -144.691% |
| NanoVibronix, Inc. | -3.71 Million USD | -444.57% |
| Quanterix Corporation | -32.33 Million USD | 37.499% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -79.063% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 4266.804% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 93.412% |
| TransMedics Group, Inc. | -25.02 Million USD | 19.254% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 8.693% |
| NeuroMetrix, Inc. | -6.52 Million USD | -209.504% |
| Hyperfine, Inc. | -44.23 Million USD | 54.318% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 74.257% |
| Biomerica, Inc. | -5.97 Million USD | -238.056% |
| Bone Biologics Corporation | -8.94 Million USD | -125.831% |
| AVITA Medical, Inc. | -39.16 Million USD | 48.405% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -103.026% |
| Silk Road Medical, Inc | -55.74 Million USD | 63.746% |